The interplay of guest encapsulation and release mechanisms in nanoscale metal-organic vehicles and its effect on the drug delivery kinetics of these materials were investigated via a novel multidisciplinary approach. Two rationally-designed molecular guests were synthesised, which consist of a red-fluorescent benzophenoxazine dye convalently tethered to a coordinating catechol group and a protected, non-coordinating catechol moiety. This allowed loading of the guests into compositionally and structurally equivalent coordination polymer particles through distinct encapsulation mechanisms: coordination and mechanical entrapment. The two types of particles delivered their fluorescent cargo with remarkably different kinetic profiles, which could be satisfactorily modelled considering degradation-and diffusion-controlled release processes. This demonstrates that careful selection of the method of guest incorporation into coordination polymer nanoparticles allows selective tuning of the rate of drug delivery from these materials and, therefore, of the time window of action of the encapsulated therapeutic agents.
Introduction
Coordination polymer particles (CPPs) have recently emerged as a novel family of metal-organic materials formed by self-assembly of metal ions and polydentate bridging ligands. 1, 2 Together with crystalline metal-organic frameworks (MOFs), CPPs have been proposed for a large variety of applications owing to the intrinsic versatility of coordination chemistry, which allows the properties of the final materials to be rationally tailored by proper choice of metals and ligands. 3 Of special interest is the use of CPPs in medicine, which is predicted to have a broad impact in the fields of bioimaging and drug delivery. 4, 5, 6 Since the pioneering work from Mirkin and coworkers in 2005, 1 an increasing number of reports have indeed described the successful application of nanoscale coordination polymer particles to encapsulate and release therapeutic agents. 6 Nonetheless, the use of CPPs for drug delivery is in its fledgling stage. A detailed rationalisation of guest encapsulation and release mechanisms is still required to understand the drug delivery kinetics of most CPPs and, consequently, to fully assess their potential use as nanocarriers for therapeutic purposes. While these issues have already been subject of extensive debate for biodegradable organic polymer vehicles as drug delivery systems, 7, 8, 9 little attention has so far been paid to them in the case of the emerging CPP-based materials.
Incorporation of the active molecules in coordination polymer nanoparticles usually proceeds via two distinct strategies: (1) binding of the drug to the polymer framework as a CPP building block 10, 11, 12, 13, 14 and (2) mechanical entrapment of the therapeutic agent within the metal-organic matrix. 15, 16, 17 Accordingly, drug release can take place though different mechanisms, namely slow particle degradation via surface erosion, fast diffusion processes and/or a combination of both. This scenario can be even more intricate if undesired desorption from the particle surface occurs. As a result, complex drug delivery profiles are often encountered in CPPs that preclude unambiguous elucidation of the relationship between encapsulation and release mechanisms.5 ,16 To share more light into this issue, we have envisioned the fabrication of morphologically equivalent CPPs bearing a fluorescent guest that can be either coordinated to the polymer backbone (M1) or physically encapsulated within the particle (M2). These two materials therefore represent excellent benchmark systems to comparatively investigate degradation-and diffusion-controlled drug release processes in CPPs. A schematic representation of this approach is shown in Fig. 1 . The molecular guest of choice for these studies is a red-fluorescent benzophenoxazine dye convalently linked to a coordinating catechol group, both in its nonprotected (1) and protected forms (2) . On the other side, cobalt nanoparticles with general composition [Co(bix) (3,5-dbsq) (3,5-dbcat) ] were used as carriers, where bix is a flexible bisimidazole bridging ligand and 3,5-dbsq and 3,5-dbcat stand for the semiquinonate radical and catecholate forms of the 3,5-di-tert-butylcatechol. 15, 16, 18 Although analogous CPPs containing Zn II ions and bix ligands have already been reported and evaluated for drug delivery applications, 15, 16 the choice of [Co(bix)(3,5-dbsq) (3,5-dbcat) ] nanoparticles is justified by: (1) the high affinity of catechol groups to coordinate to cobalt ions, which provided us with a simple way to incorporate the fluorescent guest to the polymer backbone in M1 without modification of the coordination sphere; (2) the well-known optical properties of [Co (3,5- 
Results and Discussion
Synthesis and characterization of fluorescent guests 1 and 2. Scheme 1 shows the synthetic route followed to obtain 1 and 2. Briefly, the tert-butylation and subsequent allylic oxidation of commercial 2-methoxy-4-methylphenol gave known aldehyde 3 in 97% yield, 20 which is a common intermediate for both target compounds. At this point, synthetic pathways diverged, either temporally protecting the hydroxyl groups of the catechol moiety as the corresponding methoxymethylethers, foresighting to obtain compound 1, or permanently derivatizating them as the methyl ethers found in compound 2. Thus, known intermediate 4a was obtained from 3 by sequential demethylation with BBr 3 , and protection of the corresponding catechol with methoxymethylbromide (90% overall yield). 21 Methylation of the free hydroxyl of compound 3 gave previously described derivative 4b (90%).
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Next synthetic steps are analogous for both target compounds. The Wittig reaction between aldehydes 4a and 4b and the stabilized phosphorane 2-(triphenylphosphoranylidene) acetonitrile afforded the corresponding olefins 5a (96% yield) and 5b (72% yield), as mixtures of Z-and Eisomers. Successive hydrogenation of the alkene moieties, at high pressure of H 2 under Pd/C catalyst, and nitriles, with LiAlH 4 , furnished amines 7a and 7b in 61 and 51% overall yields for both reduction reactions, respectively. After this, troublesome formation of amides 8a (31% yield) and 8b (35% yield) was achieved by reaction between amines 7a and 7b and 3-(naphthalen-1-ylamino) propanoic acid, using 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDCI) as coupling agent. 23 Compounds 1 and 2 were finally obtained by reaction between naphthylamines 8a and 8b and N-ethyl-5-hydroxy-2-methyl-4-nitrosobenzenaminium chloride in methanol, under acidic catalyst and reflux temperature (45% and 35% yield for 1 and 2, respectively). 24 Importantly, this last step did not only allow the benzophenoxazine dye group of both fluorescent guests to be constructed, but also concomitant cleavage of the methoxymethylethers to eventually obtain compound 1.
Once synthesised, the optical properties of compounds 1 and 2 were investigated in detail. Fig.  2 plots the absorption and fluorescence emission spectra of these species in methanol, which are mainly governed by the optical transitions corresponding to their benzophenoxazine dye unit. As a result, compounds 1 and 2 display equivalent absorption (λ max,1 =625 nm, λ max,2 =626 nm, ε max,1 =ε max,2 =4.8x10 4 M -1 cm -1 ) and emission bands (λ max,1 =643 nm, λ max,2 =645 nm), which resemble those reported for similar derivatives. 25 Importantly, covalent tethering of the benzophenoxazine unit to catechol and o-methoxyanisole groups in 1 and 2 does not quench its inherent emissive behaviour, the resulting dyads thus presenting high fluorescence quantum yields (Φ f,1 =0.40, Φ f,2 =0.41). Together with their long-wavelength absorption and emission spectra, this makes compounds 1 and 2 ideal fluorescent reporters to monitor guest release from CPPs as well as particle degradation.
Fabrication and characterization of M1 and M2 CPPs. Adapting an experimental procedure previously published by us, 18 coordination polymer particles M1 and M2 were prepared by reaction of Co II ions with the ditopic ligands 1,4-bis(imidazol-1-ylmethyl)benzene and 3,5-ditert-butylcatechol in the presence of guest compounds 1 and 2 (Fig. 3a) . This led to the formation of [Co(bix)(3,5-dbsq)(3,5-dbcat)] polymers, which readily precipitated as nanoparticles due to their low solubility in the reaction medium. The resulting CPPs were subsequently collected by centrifugation, washed with 5:1 water:ethanol mixtures until no red fluorescence was observed in the supernatant solution, and finally dried. For comparison purposes, guest-free coordination polymer nanoparticles (M0) were also prepared using this methodology. Noticeably, very small amounts of compounds 1 and 2 were used in the preparation of materials M1 and M2 (catechol:guest molar ratio ~ 100:1). With such low doping loads we intended to minimize the effect of the fluorescent guests on the formation of the nanoparticles, which should allow us to unambiguously ascribe the differences observed in their release profiles to the occurrence of distinct guest incorporation and delivery mechanisms.
Formation of morphologically equivalent CPPs was indeed revealed by scanning (SEM) and transmission (TEM) electron microscopy images (Fig. 3b-c and see also Fig. S1 in the Supporting Information). In all cases nanometer-sized solid particles with spherical shapes and rather uniform and similar diameters (195 ± 38, 152 ± 22 and 185 ± 37 nm for M0, M1 and M2, respectively) were obtained. X-ray diffraction experiments confirmed the amorphous character of these materials, while spectroscopic characterisation upon dissolution of the nanoparticles in degassed methanol revealed the occurrence of different electronic absorption bands arising from their constituent functional units (Fig. 4a) . Thus, an absorption band at λ∼625 nm was selectively found in the spectra of M1 and M2, which corresponds to the fluorescent benzophenoxazine moiety loaded in these materials. On the contrary, the other absorption bands at λ∼400, 590 and 700 nm were not only encountered in the spectra of M1 and M2, but also observed for guest-free M0. These can be ascribed to intraligand and metal-to-ligand/ligand-to-metal charge transfer electronic transitions of the [Co(bix)(3,5-dbsq)(3,5-dbcat)] system. 26 Noticeably, these absorption bands corresponding to the coordination complex units expand all over the UV, vis and NIR regions, and therefore they overlap with the emission spectrum of the benzophenoxazine dye (see Fig. 2a ). Consequently, efficient quenching of dye fluorescence via resonant energy transfer processes is expected in the interior of the nanoparticles, where these moieties will be located at the near proximity of coordination complex units regardless of whether they are directly coordinated to the metal centre or physically encapsulated within the polymer network. Indeed, no red fluorescence could be measured for M1 and M2 particles in the solid state, which confirms effective quenching of the emission of the loaded guests (Fig. 4b ).
Fluorescence quenching is however inhibited upon guest release and CPP degradation, which allowed us to monitor the delivery of the particle cargo by means of highly sensitive emission measurements (vide infra). This was demonstrated by measuring the optical properties of M0, M1 and M2 in non-degassed methanol, where particle dissolution is followed by coordination polymer degradation via ligand exchange and concomitant oxidation of the catecholate and semiquinone groups. This leads to disappearance of the absorption bands associated to the [Co(bix)(3,5-dbsq)(3,5-dbcat)] coordination polymers as well as pronounced growth of the band at λ∼400 nm corresponding to the quinone species resulting from catecholate and semiquinone degradation (see Fig. S2 in the Supporting Information). 27 Accordingly, no energy transfer processes are expected under such conditions and an enormous increase in benzophenoxazine emission was indeed measured (Fig. 4b ). The absorption measurements in non-degassed methanol were also used to quantify the encapsulation efficiencies for the preparation of dyedoped M1 and M2 particles. Interestingly, higher values were obtained for M1 (∼20%) than for M2 (∼10%) under equivalent experimental conditions, which indicates that incorporation of the fluorescent guest bearing a coordinating catechol moiety is significantly more effective. 2 ] tautomers by intramolecular metalligand electron transfer, a process that can be selectively monitored by temperature dependent measurements of magnetic susceptibility. In all cases, an abrupt change in effective magnetic moment (µ eff ) is observed around 300 K, which is consistent with valence-tautomeric interconversion from low-to high-spin states for a large fraction of molecules in the nanoparticles. 18 Importantly, the occurrence of valence tautomerism and the actual profile of the corresponding µ eff vs T plot is not only highly sensitive to metal complex composition and structure, but also to the local environment. 19 In other words, the same complex may exhibit or not VT, or the low-spin-to-high-spin conversion might take place at different temperatures depending on structural and environmental parameters. Therefore, the extremely similar magnetic behaviour encountered for M0, M1 and M2 clearly indicates that they must be formed by equivalent coordination polymers in rather comparable phases. 100 hours. Relative cumulative release profiles were then measured by monitoring the fluorescence of the dialysis bath solution in time. In addition, the solid material remaining in the dialysis bag after 100 hours was dissolved in methanol and characterised by absorption spectroscopy, which allowed us to determine the absolute release efficiency of the dialysis experiment. Fig. 6 plots the cumulative release profiles measured for M1 and M2 under these experimental conditions. Both exhibit very high release efficiencies after 100 hours (~90%) with no "burst effects" associated to undesired desorption of guest molecules physisorbed onto the nanoparticle surface. However, the release kinetics measured for these materials were found to be strikingly different. In the case of M2, the delivery process was nearly completed after 8 h (t 1/2 ~1.2 h), a behaviour resembling that already reported for the release of anticancer drugs mechanically entrapped in analogue [Zn(bix)] CPPs. 16 In contrast, a much slower process was observed for M1, which required about 100 h for completion (t 1/2 ~11 h).
On the basis of the non-coordinating nature of the encapsulated guest, the release profile of M2 at 37ºC was fitted with a purely diffusion-controlled model of drug delivery. In particular, we considered the use of equation (1), which was derived for drug delivery via Fickian diffusion from spherical particles with homogenous and low-doping loads that do not significantly swell or degrade during the release process:
In this equation, M t and M∞ represent the cumulative absolute amounts of guest released at time t and infinity, R is the radius of the particles and D is the apparent diffusion constant of the drug within the system. D is the only variable parameter in this model, which is taken to remain constant throughout the release process by neglecting swelling and degradation effects on the structure of the polymeric drug carrier.
As observed in Fig. 6 , a rather satisfactory fit of the experimental release kinetics of M2 was obtained using equation (1) . Therefore, the delivery of the mechanically-entrapped fluorescent guest must be governed by a time-independent diffusion mechanism (D = 6.9x10 -19 m 2 s -1 ), which indicates that the influence of degradation processes on the release kinetics is negligible in this case even though it takes place. This is proven by Fig. 7 , which displays SEM images of M2 nanoparticles suspended in aqueous media at 37ºC for 0, 5, 26 and 100 h. While most particles preserved their spherical shape after 5 h, extensive surface erosion and an increasing amount of non-structured material is observed in the SEM images registered at 26 and 100 h. This confirms CPP degradation, which however takes place at a longer time scale than guest diffusion from the nanoparticles at 37ºC. This is in contrast with other systems for which clearly different delivery phases are observed that are ascribed to the occurrence of sequential fast diffusion and slow degradation processes.
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The release profile obtained for M1 at 37ºC was also tentatively fitted with single-mechanism models, which in this case should solely account for degradation-controlled delivery. However, poor agreement between the experimental and fitted release profiles was obtained regardless of using surface-degradation 29 or bulk-degradation 30 models of drug delivery. This suggests the occurrence of a more complex release process, which we attempted to model by assuming simultaneous delivery via degradation and diffusion processes. In this scenario, degradationcontrolled release should apply for all guest molecules coordinated to the polymeric backbone, while those that remain unbound but physically entrapped within the metal-organic matrix should be preferentially delivered by fast diffusion processes. Based on the previous results obtained for M2 and analogue [Zn(bix)] CPPs, 16 equation (2) was derived to account for such situation:
The first term in this equation corresponds to the Fickian diffusion model already applied to M2, where b is the fraction of guest molecules that lie mechanically entrapped within M1 particles. As previously discussed, this model assumes that the diffusion-controlled release of guest molecules takes place before significant degradation of the polymer matrix occurs, which allows the particle radius and the apparent guest diffusion constant to be considered time independent. This assumption is not only supported by the behaviour observed for M2, but also by the similar results obtained when monitoring the degradation process of M1 nanoparticles at 37ºC in water media using SEM (see Fig. S3 in the Supporting Information). The second term in equation (2) corresponds to an empirical model that has been developed for degradation-controlled drug delivery from spherical particles via surface erosion, 29 which is indeed the degradation mechanism reported for analogue [Zn(bix)] CPPs at physiological conditions. 16 In this expression (1-b) is the fraction of guest molecules coordinated to the metal centres in M1, k d is the surface erosion rate constant, C 0 is the total initial concentration of the guest in the polymer matrix (7.2x10 -4 % (w/w)) and R is the initial radius of the nanoparticles.
To fit equation (2) to the guest release profile measured for M1 at 37ºC, only two variable parameters were considered: b and k d . To test the consistency of our model, D was directly taken from the previous fit of M2 delivery kinetics, a rather plausible constraint based on the very similar structures of the guest compounds and coordination polymer particles investigated in this work. As observed in Fig. 6 , a good agreement was encountered between the experimental and fitted release profiles of M1 even under such assumption, which proves the validity of our treatment (b = 0.26, k d /(C 0 R)= 1.7x10 -6 s -1 ). From this we conclude that most guest molecules in M1 nanoparticles (74%) are directly bound to the polymer matrix, which are therefore released by slow degradation of the material. Nevertheless, a significant fraction of them (26%) are not coordinated to cobalt ions despite presenting free catechol groups, but they were physically encapsulated during the formation of the particles. Accordingly, they are delivered via a fast time-independent diffusion mechanism similar to that encountered for M2 CPPs.
Additional guest release experiments were performed at 60ºC aiming at investigating the temperature dependence of the delivery processes in these materials (see Fig. S4 in the Supporting Information). In deep contrast to what had been observed at 37ºC, no significant differences were found between the release profiles measured for M1 and M2 at this temperature. In both cases, complete delivery of the fluorescence guests is observed at ∼5 h, revealing the occurrence of much faster release processes. This suggests that degradation kinetics enormously accelerates at 60ºC, which must become at least comparable to guest diffusion rates. As a matter of fact, we expect the release profiles of M1 and M2 CPPs at these conditions to be mainly governed by degradation processes, which indicates that both the guest delivery kinetics and mechanisms of these materials can be dramatically altered by temperature control.
Conclusion
In this work we report a novel rational approach to investigate the relationship between guest encapsulation and release mechanisms for metal-organic nanoparticles. By proper design of the guest compounds and particle formation conditions, two types of coordination polymer particles were prepared that (1) are compositionally and structurally equivalent, and (2) were loaded with the same fluorescent guests using different encapsulation processes. As a result, the release of their fluorescent cargo at physiological conditions proceeds via distinct mechanisms that converge upon increasing the temperature. Physically encapsulated guest molecules are delivered by fast time-independent diffusion processes, while the release of coordinated guest moieties is governed by slow particle degradation. This leads to remarkably different guest delivery profiles for the CPPs prepared, which demonstrates that the kinetics of release can be selectively tuned up to many hours by appropriate choice of the mechanism of incorporation of the therapeutic agent into the polymeric nanocarrier. This result opens new venues for the future use of CPPs in medicine owing to the feasibility of loading drugs into these carriers by both mechanical entrapment and chemical binding to the metal centres. The former encapsulation mechanism has indeed already been demonstrated for anticancer drugs, 16 while tethering of these molecules to coordinating ligands could be attempted via functional groups that are readily cleaved at physiological conditions (e.g. ketals 31 ), thus rendering the active form of the therapeutic agent after degradation-induced release from the polymer particles. As a result, controlling the ratio of coordinated vs. physically entrapped drug molecules within CPPs would eventually allow tailoring the release kinetics to meet the therapeutic needs.
Experimental Section
Materials and characterisation: All reactants and reagents were purchased from Sigma-Aldrich and used as received. Solvents were purchased from Scharlab and used as received. Dialysis bags were purchased from Orange Scientific.Infrared spectra were recorded on a Bruker Tensor 27 spectrometer equipped with a Golden Gate Single Reflection Diamond ATR (Attenuated Total Reflectance) accessory. High resolution mass analyses were performed on an ESI-QTOF Bruker Daltonics micrOTOF-Q spectrometer. NMR spectra were recorded on a Bruker ARX 400 (400 MHz for 1 H NMR and 100 MHz for 13 C NMR). The spectra are given in δ (ppm) using the signal of the residual non-deuterated solvent molecules as reference. Absorption spectra were recorded on a Hewlett Packard 8453 spectrophotometer. HPLC or spectroscopy quality solvents were used. Emission spectra were measured by means of a custom-made spectrofluorimeter, where a cw HeNe REO laser (λ exc = 594 nm) was used as excitation source and the emitted photons were detected in an Andor ICCD camera coupled to a spectrograph. HPLC or spectroscopy quality solvents were used. Fluorescence quantum yields were determined using Nile Blue A in ethanol solution as reference (Φ f =0.27). 32 SEM measurements were registered on a HITACHI S-570 microscope (accelerating voltage 0.5-30 kV). TEM measurements were carried out on a HITACHI-7000 microscope operating at 125 kV. 
Synthesis of compound 4a:

Synthesis of 5a.
To a solution of 4a (1.559 g, 5.53 mmol) in toluene (45 mL), (triphenylphosphoranylidene)acetonitrile (2.070 g, 6.87 mmol) was added. The reaction mixture was heated under reflux for 12h, after which the solvent was evaporated under vacuum and the residue was purified by flash chromatography using hexanes and ethyl acetate (6:1, v/v) to afford a mixture of (E)-and (Z)-5a (1.621 g, 96 %) as a brown oil with a diastereomeric ratio of 2.3:1. 
Synthesis of 6a.
A mixture of (E)-and (Z)-5a (1.442 g, 4.8 mmol) and 10% Pd/C (5:1, substrate/catalyst) in ethyl acetate (16 mL) was stirred at room temperature under hydrogen atmosphere for 24 h. Next, Pd/C was filtered off and the solvent was removed in vacuo. The residue was purified by flash chromatography using hexanes and ethyl acetate (3:1, v/v) to afford 6a (1.003 g, 68 %) as a brown oil. 1 Guest release experiments. A dialysis bag (cut-off molecular weight: 3500) containing M1 or M2 (c ~ 3 mg/mL) dispersed in phosphate buffered saline solution (PBS; pH = 7.4) was placed in 150 mL of PBS (pH = 7.4; dialysate) at 37 ºC under light stirring. To determine the increase of 1 or 2 concentration diffused through the dialysis bag, 0.5 mL of external PBS solution were taken from the dialysate at prefixed times and diluted in 2 mL of MeOH, and each aliquot was analyzed by fluorescence spectroscopy. The solid material remaining in the dialysis bag after 100 hours was dissolved in methanol and characterised by absorption spectroscopy. 
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Drug release mechanisms uncovered! Coordination polymer nanoparticles loaded with coordinated and mechanically entrapped fluorescent guests were prepared as benchmark systems to investigate diffusion-and degradation-controlled drug delivery from these materials.
